6-34246605-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The ENST00000636500.1(SMIM29):c.389G>A(p.Gly130Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000397 in 1,613,182 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 10/14 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
ENST00000636500.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SMIM29 | NM_001008703.4 | c.*198G>A | 3_prime_UTR_variant | 5/5 | ENST00000476320.6 | NP_001008703.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SMIM29 | ENST00000476320 | c.*198G>A | 3_prime_UTR_variant | 5/5 | 2 | NM_001008703.4 | ENSP00000417604.2 |
Frequencies
GnomAD3 genomes AF: 0.000191 AC: 29AN: 152180Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000561 AC: 14AN: 249720Hom.: 0 AF XY: 0.0000444 AC XY: 6AN XY: 135044
GnomAD4 exome AF: 0.0000240 AC: 35AN: 1461002Hom.: 0 Cov.: 62 AF XY: 0.0000193 AC XY: 14AN XY: 726704
GnomAD4 genome AF: 0.000191 AC: 29AN: 152180Hom.: 0 Cov.: 33 AF XY: 0.000175 AC XY: 13AN XY: 74330
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 30, 2021 | The c.389G>A (p.G130D) alteration is located in exon 5 (coding exon 3) of the C6orf1 gene. This alteration results from a G to A substitution at nucleotide position 389, causing the glycine (G) at amino acid position 130 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at